Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
LSD
amphetamine Hallucinogen |
| gptkbp:actsOn |
serotonin receptor agonist
|
| gptkbp:CASNumber |
1043868-97-8
|
| gptkbp:chemicalFormula |
C18H23NO2
|
| gptkbp:discoveredBy |
gptkb:Ralf_Heim
|
| gptkbp:discoveredIn |
2003
|
| gptkbp:effect |
euphoria
hallucinations stimulation visual distortions |
| gptkbp:hasStreet |
gptkb:Smiles
N-Bomb NBOMe |
| https://www.w3.org/2000/01/rdf-schema#label |
25H-NBOMe
|
| gptkbp:IUPACName |
2-(4-methoxybenzyl)-N-(2-methoxybenzyl)ethanamine
|
| gptkbp:legalStatus |
controlled substance in some countries
|
| gptkbp:molecularWeight |
285.38 g/mol
|
| gptkbp:relatedTo |
gptkb:25C-NBOMe
gptkb:25I-NBOMe gptkb:2C-H |
| gptkbp:riskFactor |
death
overdose seizures vasoconstriction |
| gptkbp:routeOfAdministration |
oral
insufflation sublingual |
| gptkbp:bfsParent |
gptkb:NBOMe_series
|
| gptkbp:bfsLayer |
7
|